Abatacept: all 220 studies that test it
Page 2 of 3. Open to participants first (30), then studies with results posted, then the rest; newest registration first within each.
- Safety Study of Abatacept to Treat Refractory SarcoidosisTerminatedNCT00739960Phase 2Results posted
- Phase I Study in China - Tolerability of a Single Dose of Abatacept 30 mg/kgCompletedNCT00705367Phase 1Results posted
- Phase IIIB Switching From Intravenous to Subcutaneous StudyCompletedNCT00663702Phase 3Results posted
- Belatacept Pharmacokinetic Trial in Renal TransplantationCompletedNCT00578448Phase 2Results posted
- Subcutaneous Pharmacokinetics of BelataceptCompletedNCT00569803Phase 1Results posted
- Belatacept Post Depletional Repopulation to Facilitate ToleranceCompletedNCT00565773Phase 2Results posted
- Methotrexate-Inadequate Response StudyCompletedNCT00559585Phase 3Results posted
- Abatacept for Treating Adults With Giant Cell Arteritis and Takayasu's ArteritisCompletedNCT00556439Phase 2Results posted
- Safety and Efficacy of Abatacept Versus Placebo in Participants With Psoriatic ArthritisTerminatedNCT00534313Phase 2Results posted
- Phase IIIB Subcutaneous Missed Dose StudyCompletedNCT00533897Phase 3Results posted
- Intravenous CTLA4-lg Treatment in Recent Onset Type 1 Diabetes MellitusCompletedNCT00505375Phase 2Results posted
- A Phase III Study of Abatacept in Japanese Subjects With Rheumatoid ArthritisCompletedNCT00484289Phase 3Results posted
- Abatacept in Treating Adults With Mild Relapsing Wegener's GranulomatosisCompletedNCT00468208Phase 1/2Results posted
- A Phase II Study of Belatacept (BMS-224818) With a Steroid-free Regimen in Subjects Undergoing Kidney TransplantationCompletedNCT00455013Phase 2Results posted
- A Study to Evaluate the Safety and Efficacy of Abatacept in Patients With Diffuse Systemic Sclerosis (Scleroderma)CompletedNCT00442611Phase 1/2Results posted
- Efficacy and Safety Study of Abatacept to Treat Lupus NephritisTerminatedNCT00430677Phase 2/3Results posted
- A Phase IIIb Study of BMS-188667 in Subjects With Active Rheumatoid Arthritis and Inadequate Response to MethotrexateCompletedNCT00420199Phase 3Results posted
- A Study of Abatacept in Patients With Active Ulcerative ColitisCompletedNCT00410410Phase 3Results posted
- A Phase III Study of Abatacept in Patients With Rheumatoid Arthritis and an Inadequate Response to MethotrexateCompletedNCT00409838Phase 3Results posted
- A Study of Abatacept in Patients With Active Crohn's DiseaseTerminatedNCT00406653Phase 3Results posted
- A Study of BMS-224818 (Belatacept) in Patients Who Have Undergone a Kidney Transplant and Are Currently on Stable Cyclosporine or Tacrolimus Regimen With or Without CorticosteroidsCompletedNCT00402168Phase 2Results posted
- Belatacept to Prevent Organ Rejection in Kidney Transplant PatientsTerminatedNCT00346151Phase 2Results posted
- Islet Transplantation Using AbataceptCompletedNCT00276250Phase 2Results posted
- Study to Assess Steady-State Trough Concentrations, Safety, and Immunogenicity of Abatacept After Subcutaneous (SC) Administration to Subjects With Rheumatoid Arthritis (RA)CompletedNCT00254293Phase 1/2Results posted
- Abatacept With Methotrexate- Phase IIBCompletedNCT00162266Phase 2Results posted
- Study of Abatacept Versus Placebo to Assess the Prevention of Rheumatoid Arthritis (RA) in Adult PatientsCompletedNCT00124449Phase 2Results posted
- Remission and Joint Damage Progression in Early Rheumatoid ArthritisCompletedNCT00122382Phase 3Results posted
- Abatacept in the Treatment and Prevention of Active Systemic Lupus Erythematosus (SLE) Flares in Combination With PrednisoneCompletedNCT00119678Phase 2Results posted
- BMS-188667 in Children and Adolescents With Juvenile Rheumatoid ArthritisCompletedNCT00095173Phase 3Results posted
- Abatacept and Infliximab in Combination With Methotrexate in Subjects With Rheumatoid ArthritisCompletedNCT00095147Phase 3Results posted
- A Phase III Study of BMS-188667 in Subjects With Active Rheumatoid ArthritisCompletedNCT00048932Phase 3Results posted
- Phase III Study of BMS-188667 (CTLA4Ig) in Patients With Rheumatoid Arthritis Who Are Currently Failing Anti-TNF Therapy or Who Have Failed Anti-TNF Therapy in the Past.CompletedNCT00048581Phase 3Results posted
- A Phase III Study of Abatacept (BMS-188667) in Patients With Active Rheumatoid Arthritis and Inadequate Response to MethotrexateCompletedNCT00048568Phase 3Results posted
- Study Comparing the Safety and Efficacy of Belatacept With That of Cyclosporine in Patients With a Transplanted KidneyCompletedNCT00035555Phase 2Results posted
- Open Label , Randomized, Three Arm Parallel Group Single Dose Comparative Pharmacokinetic , Safety and Immunogenicity Study in Healthy SubjectsCompletedNCT06929039Phase 1
- ABBA CORD: dCBT w/ Abatacept for aGVHD ProphylaxisSuspendedNCT06680661Phase 2
- Study in ALS With Abatacept & IL-2CompletedNCT06307301Phase 1
- A Study to Evaluate the Drug Levels of Abatacept Converted From Drug Substance by Two Different Processes in Healthy ParticipantsCompletedNCT05981976Phase 1
- Insulin and Abatacept in Recently-diagnosed Type 1 DiabetesCompletedNCT05742243Phase 2
- A Study of TCD601 in de Novo Renal Transplant RecipientsCompletedNCT05669001Phase 2
- Cyclophosphamide, Abatacept, and Tacrolimus for the Prevention of GvHDActive, not recruitingNCT05621759Phase 2
- Novel Desensitization Kidney TransplantationCompletedNCT05345717Phase 1/2
- A Study to Evaluate Efficacy and Safety of Abatacept in Participants of Pemphigus Vulgaris (PV)Status unknownNCT05303272Phase 4
- AbataCept for the Treatment of Immune-cHeckpoint Inhibitors Induced mYocarditiSCompletedNCT05195645Phase 2
- COVID-19 VaccinE Response in Rheumatology PatientsCompletedNCT05080218Phase 4
- Carfilzomib and Belatacept for DesensitizationActive, not recruitingNCT05017545Phase 1/2
- Abatacept Conversion in Kidney TransplantationCompletedNCT04955366Phase 2
- An Exploratory Study on the Efficacy and Safety of Abatacept in the Treatment of Refractory DermatomyositisStatus unknownNCT04946669Early Phase 1
- Adjuvant Treatment With Abatacept to Promote Remission During Peanut Oral ImmunotherapyCompletedNCT04872218Phase 2
- Daratumumab and Belatacept for DesensitizationCompletedNCT04827979Phase 1/2
- Abatacept for Patients With COVID-19 and Respiratory DistressWithdrawnNCT04477642Phase 1/2
- Impact of T Cells on Age-related Vascular Dysfunction: A Translational ApproachWithdrawnNCT04344873Early Phase 1
- Abatacept in Individuals Who aRe Considered At Risk of Developing Inflammatory ArthritisTerminatedNCT04261023Phase 2
- Biologics for Rheumatoid Arthritis Pain (BIORA-PAIN)CompletedNCT04255134Phase 4
- Abatacept for Treatment of Recurrent or de Novo Autoimmune HepatitisTerminatedNCT04203875Phase 1
- TOLERA: Tolerance Enhancement in RAStatus unknownNCT04120831Phase 2
- Early Markers of Disease and Response to TherapyCompletedNCT04118153Early Phase 1
- Abatacept Bone Effects in Psoriatic Arthritis With Bone BiomarkerStatus unknownNCT04106804Phase 4
- Rituximab-pvvr and Abatacept vs Rituximab-pvvr Alone in New Onset Type 1 DiabetesActive, not recruitingNCT03929601Phase 2
- Acute GVHD Suppression Using Costimulation Blockade to Expand Non-malignant TransplantActive, not recruitingNCT03924401Phase 2
- Abatacept in Patients With Birdshot HLA A29 UveitisCompletedNCT03871361Phase 2
- Lung Transplant Plasmapheresis/Belatacept/Carfilzomib for Antibody Mediated Rejection and DesensitizationWithdrawnNCT03805178Phase 2
- Safety and Efficacy of Abatacept for Treating Chronic Cytopenia in Cytotoxic T-Lymphocyte Antigen 4 (CTLA4) HaploinsufficiencyWithdrawnNCT03733067Phase 1/2
- EFFECTS OF ABATACEPT on the Progression to Rheumatoid Arthritis(PALABA Study)CompletedNCT03669367Phase 4
- Abatacept in earLy Onset Polymyalgia Rheumatica: Study ALORSCompletedNCT03632187Phase 3
- Abatacept to Silence Anti-citrullinated Protein Antibody-expressing B Cells in Rheumatoid Arthritis (ASCARA)CompletedNCT03492658Phase 4
- Sjogrens Syndrome Measured by UltrasoundStatus unknownNCT03411850Phase 2
- A Study Using Healthy Volunteers Comparing Belatacept Which Has Been Manufactured By 2 Different ProcessesCompletedNCT03375138Phase 1
- A Study to Evaluate Efficacy and Safety of Subcutaneous Abatacept With Steroid Treatment Compared to Steroid Treatment Alone in Adults With Giant Cell Arteritis (GCA)WithdrawnNCT03192969Phase 3
- APRIL (AbatacePt in Rheumatoid Arthritis-ILD)Status unknownNCT03084419Phase 2
- Trial of Orencia in Patients With Myasthenia GravisTerminatedNCT03059888Early Phase 1
- Precision Medicine Offers Belatacept MonotherapyWithdrawnNCT02939365Phase 4
- Abatacept for GVHD Prophylaxis After Hematopoietic Stem Cell Transplantation for Pediatric Sickle Cell DiseaseCompletedNCT02867800Phase 1
- Treatment Tapering in JIA With Inactive DiseaseCompletedNCT02840175Phase 3
- Pharmacokinetics, Safety and Tolerability Study of Single Dose of Abatacept 125mg Administered SubcutaneouslyStatus unknownNCT02805010Phase 1
- Abatacept Reversing Subclinical Inflammation as Measured by MRI in ACPA Positive ArthralgiaCompletedNCT02778906Phase 3
- Belatacept (Nulojix) in Renal Transplant Recipient With Mild Immunologic Risk Factor: a Pilot Prospective Study.CompletedNCT02738918Phase 2
- A Phase 3 Study of Abatacept in Chinese Patients With Active Rheumatoid Arthritis and Inadequate Response to MethotrexateStatus unknownNCT02722694Phase 3
- Inhibition of Co-Stimulation in Rheumatoid ArthritisStatus unknownNCT02652273Phase 4
- Dose Reduction for Early Rheumatoid Arthritis Patients With Low Disease ActivityStatus unknownNCT02466581Phase 4
- Open-label Pilot Study of Abatacept for the Treatment of VitiligoStatus unknownNCT02281058Phase 1
- Belatacept for Renal Transplant Recipients With Delayed Graft FunctionTerminatedNCT02134288Early Phase 1
- Belatacept in Kidney Transplantation of Moderately Sensitized PatientsWithdrawnNCT02130817Phase 4
- Abatacept for the Treatment of Relapsing, Non-Severe, Granulomatosis With Polyangiitis (Wegener's)CompletedNCT02108860Phase 3
- Efficacy and Safety of Abatacept in Patients With Primary Sjögren's SyndromeCompletedNCT02067910Phase 3
- Abatacept vs Placebo in RA Patients With Hepatitis B on Entecavir BackgroundWithdrawnNCT02053727Not applicable
- Abatacept for Patients With Inflammatory Arthritis Associated With Sjögren's Syndrome: an Open-Label Phase II StudyWithdrawnNCT02027298Phase 2
- Bone Marrow Transplant With Abatacept for Non-Malignant DiseasesCompletedNCT01917708Phase 1
- A Clinical Trial to Evaluate the Efficacy of Abatacept in Moderate to Severe Alopecia AreataWithdrawnNCT01917058Phase 2
- Comparison of NODAT in Kidney Transplant Patients Receiving Belatacept Versus Standard ImmunosuppressionStatus unknownNCT01875224Phase 4
- Introducing a Single IV Abatacept Treatment in RA Patients Currently Receiving Weekly SC Abatacept to Simulate a HolidayCompletedNCT01846975Phase 4
- Early Conversion From CNI to Belatacept in Renal Transplant Recipients With Delayed and Slow Graft FunctionStatus unknownNCT01837043Phase 2
- Abatacept Post-marketing Clinical Study in JapanCompletedNCT01758198Phase 4
- Effect on Orencia (Abatacept) on the Apoptosis of T Cells, B Cells and APC Cells in Rheumatoid ArthritisWithdrawnNCT01717846Phase 4
- A Pilot Study of the Safety and Efficacy of Abatacept Injections in the Treatment of Behcet's SyndromeCompletedNCT01693640Early Phase 1
- A Randomized, Multi-Center Biomarker Trial to Predict Therapeutic Responses of Patients With Rheumatoid Arthritis to a Specific Biologic Mode of ActionCompletedNCT01638715Phase 4
- Belatacept in Renal Transplantation With Intermediate Risk Maryland Aggregate Pathology Index (MAPI) ScoresCompletedNCT01496417Not applicable
- Active Conventional Therapy Compared to Three Different Biologic Treatments in Early Rheumatoid Arthritis With Subsequent Dose ReductionStatus unknownNCT01491815Phase 4
- Impact of Subcutaneous Abatacept in Rheumatoid Arthritis Assessing Inhibition of Structural DamageCompletedNCT01333878Phase 2/3
- Abatacept Treatment in Polymyositis and DermatomyositisCompletedNCT01315938Phase 2